GlassScriptPhysician profile
Che Antonio Solla
NPI 1598078909
$7,296.49
in general payments reported to CMS, 2019-2025
25 companies · $220 in 2025
The $220 reported for 2025 was more than what 82% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $653 · 2020: $747 · 2022: $988 · 2023: $2,693 · 2024: $1,996 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,743 · Food and Beverage: $2,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,742.87 |
| Food and Beverage | $2,166.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,741.51 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Pacira Pharmaceuticals Incorporated | $1,574.67 | 2023-2025 | Iovera, Zilretta |
| Medtronic, INC. | $903.03 | 2022-2024 | Intellis Adaptivestim, Resparray, Synchromedii |
| Nevro Corp. | $413.35 | 2019-2020 | |
| Medtronic USA, INC. | $373.37 | 2019-2020 | |
| Abbott Laboratories | $212.60 | 2023-2024 | Eterna, Proclaim |
| Stimwave Technologies Incorporated | $157.11 | 2019 | |
| Mdd US Operations, LLC | $138.54 | 2020 | |
| Collegium Pharmaceutical, INC. | $123.79 | 2020 | |
| Spinefrontier, INC. | $93.59 | 2024 | Inspan |
| Spr Therapeutics, INC | $72.15 | 2022-2023 | Sprint Pns System |
| Avanos Medical | $70.11 | 2023-2024 | Coolief* Cooled Radiofrequency, Standard Rf Disposables, Generator |
| Scilex Pharmaceuticals INC. | $58.53 | 2019-2023 | Ztlido |
| Tersera Therapeutics LLC | $57.52 | 2019-2022 | |
| Grt US Holding, INC. | $56.84 | 2020-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $56.53 | 2019-2020 | |
| Averitas Pharma INC. | $41.41 | 2023-2024 | Qutenza |
| Ipsen Biopharmaceuticals, INC | $36.94 | 2022-2023 | Dysport |
| Relievant Medsystems, INC. | $19.84 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.83 | 2022 | |
| Amgen INC. | $19.17 | 2023 | Prolia, Evenity |
| Redhill Biopharma INC. | $16.73 | 2020 | |
| Pacira Therapeutics, INC. | $14.85 | 2019 | |
| Merit Medical Systems INC | $12.82 | 2023 | Stabilit |
| Takeda Pharmaceuticals U.S.A., INC. | $11.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Che Solla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.